blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2847336

EP2847336 - NUCLEIC ACID CONSTRUCT AND USE OF THE SAME [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  23.11.2018
Database last updated on 02.11.2024
FormerThe patent has been granted
Status updated on  15.12.2017
FormerGrant of patent is intended
Status updated on  23.07.2017
FormerExamination is in progress
Status updated on  10.01.2017
Most recent event   Tooltip26.06.2020Lapse of the patent in a contracting state
New state(s): MK		published on 29.07.2020  [2020/31]
Applicant(s)For all designated states
Kochanek, Stefan
Forstweg 22
89143 Blaubeuren / DE
[2018/17]
Former [2015/12]For all designated states
Kochanek, Stefan
Maienweg 84
89081 Ulm / DE
Inventor(s)01 / LUCAS, Tanja
Agricolaweg 15
D-93049 Regensburg / DE
02 / KUEPPERS, Claudia
Efringerstrasse 14
D-79576 Weil am Rhein / DE
03 / KOCHANEK, Stefan
Forstweg 22
89143 Blaubeuren / DE
 [2018/17]
Former [2015/12]01 / LUCAS, Tanja
Agricolaweg 15
D-93049 Regensburg / DE
02 / KUEPPERS, Claudia
Efringerstrasse 14
D-79576 Weil am Rhein / DE
03 / KOCHANEK, Stefan
Maienweg 84
D-89081 Ulm / DE
Representative(s)Bohmann, Armin K.
Bohmann
Anwaltssozietät
Nymphenburger Straße 1
80335 München / DE
[2015/12]
Application number, filing date13726106.107.05.2013
[2018/03]
WO2013EP01356
Priority number, dateEP2012000356407.05.2012         Original published format: EP 12003564
US201261645154P10.05.2012         Original published format: US 201261645154 P
[2015/12]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2013167265
Date:14.11.2013
Language:EN
[2013/46]
Type: A1 Application with search report 
No.:EP2847336
Date:18.03.2015
Language:EN
The application published by WIPO in one of the EPO official languages on 14.11.2013 takes the place of the publication of the European patent application.
[2015/12]
Type: B1 Patent specification 
No.:EP2847336
Date:17.01.2018
Language:EN
[2018/03]
Search report(s)International search report - published on:EP14.11.2013
ClassificationIPC:C12N15/861, C12N5/10
[2015/12]
CPC:
C12N15/86 (EP,KR,US); C12N15/85 (KR,US); C12N15/11 (KR);
C12N15/111 (KR); C12N15/861 (KR,US); C12N2710/10343 (EP,KR,US);
C12N2840/44 (EP,KR,US); C12N2840/85 (EP,KR,US) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2015/12]
Extension statesBANot yet paid
MENot yet paid
TitleGerman:NUKLEINSÄUREKONSTRUKT UND VERWENDUNG DAVON[2015/12]
English:NUCLEIC ACID CONSTRUCT AND USE OF THE SAME[2015/12]
French:CONSTRUCTION D'ACIDE NUCLÉIQUE ET SON UTILISATION[2015/12]
Biological materialThis application mentions deposited biological material, check the file for details
Entry into regional phase05.12.2014National basic fee paid 
05.12.2014Designation fee(s) paid 
05.12.2014Examination fee paid 
Examination procedure05.12.2014Examination requested  [2015/12]
14.09.2015Despatch of communication that the application is deemed to be withdrawn, reason: reply to the Extended European Search Report/Written Opinion of the International Searching Authority/International Preliminary Examination Report/Supplementary international search report not received in time
24.11.2015Amendment by applicant (claims and/or description)
16.06.2016Despatch of a communication from the examining division (Time limit: M06)
30.12.2016Reply to a communication from the examining division
07.02.2017Despatch of a communication from the examining division (Time limit: M04)
19.06.2017Reply to a communication from the examining division
24.07.2017Communication of intention to grant the patent
04.12.2017Fee for grant paid
04.12.2017Fee for publishing/printing paid
04.12.2017Receipt of the translation of the claim(s)
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  16.06.2016
Opposition(s)18.10.2018No opposition filed within time limit [2018/52]
Request for further processing for:24.11.2015Request for further processing filed
24.11.2015Full payment received (date of receipt of payment)
Request granted
11.12.2015Decision despatched
Fees paidRenewal fee
30.04.2015Renewal fee patent year 03
03.05.2016Renewal fee patent year 04
11.05.2017Renewal fee patent year 05
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU07.05.2013
AL17.01.2018
AT17.01.2018
CY17.01.2018
CZ17.01.2018
DK17.01.2018
EE17.01.2018
ES17.01.2018
FI17.01.2018
HR17.01.2018
IT17.01.2018
LT17.01.2018
LV17.01.2018
MC17.01.2018
MK17.01.2018
PL17.01.2018
PT17.01.2018
RO17.01.2018
RS17.01.2018
SE17.01.2018
SI17.01.2018
SK17.01.2018
SM17.01.2018
TR17.01.2018
BG17.04.2018
NO17.04.2018
GR18.04.2018
IE07.05.2018
LU07.05.2018
MT07.05.2018
IS17.05.2018
[2020/31]
Former [2020/28]HU07.05.2013
AL17.01.2018
AT17.01.2018
CY17.01.2018
CZ17.01.2018
DK17.01.2018
EE17.01.2018
ES17.01.2018
FI17.01.2018
HR17.01.2018
IT17.01.2018
LT17.01.2018
LV17.01.2018
MC17.01.2018
PL17.01.2018
PT17.01.2018
RO17.01.2018
RS17.01.2018
SE17.01.2018
SI17.01.2018
SK17.01.2018
SM17.01.2018
TR17.01.2018
BG17.04.2018
NO17.04.2018
GR18.04.2018
IE07.05.2018
LU07.05.2018
MT07.05.2018
IS17.05.2018
Former [2020/16]AL17.01.2018
AT17.01.2018
CY17.01.2018
CZ17.01.2018
DK17.01.2018
EE17.01.2018
ES17.01.2018
FI17.01.2018
HR17.01.2018
IT17.01.2018
LT17.01.2018
LV17.01.2018
MC17.01.2018
PL17.01.2018
RO17.01.2018
RS17.01.2018
SE17.01.2018
SI17.01.2018
SK17.01.2018
SM17.01.2018
TR17.01.2018
BG17.04.2018
NO17.04.2018
GR18.04.2018
IE07.05.2018
LU07.05.2018
MT07.05.2018
IS17.05.2018
Former [2020/08]AL17.01.2018
AT17.01.2018
CY17.01.2018
CZ17.01.2018
DK17.01.2018
EE17.01.2018
ES17.01.2018
FI17.01.2018
HR17.01.2018
IT17.01.2018
LT17.01.2018
LV17.01.2018
MC17.01.2018
PL17.01.2018
RO17.01.2018
RS17.01.2018
SE17.01.2018
SI17.01.2018
SK17.01.2018
SM17.01.2018
BG17.04.2018
NO17.04.2018
GR18.04.2018
IE07.05.2018
LU07.05.2018
MT07.05.2018
IS17.05.2018
Former [2019/19]AL17.01.2018
AT17.01.2018
CY17.01.2018
CZ17.01.2018
DK17.01.2018
EE17.01.2018
ES17.01.2018
FI17.01.2018
HR17.01.2018
IT17.01.2018
LT17.01.2018
LV17.01.2018
MC17.01.2018
PL17.01.2018
RO17.01.2018
RS17.01.2018
SE17.01.2018
SI17.01.2018
SK17.01.2018
SM17.01.2018
BG17.04.2018
NO17.04.2018
GR18.04.2018
IE07.05.2018
LU07.05.2018
IS17.05.2018
Former [2019/17]AL17.01.2018
AT17.01.2018
CY17.01.2018
CZ17.01.2018
DK17.01.2018
EE17.01.2018
ES17.01.2018
FI17.01.2018
HR17.01.2018
IT17.01.2018
LT17.01.2018
LV17.01.2018
MC17.01.2018
PL17.01.2018
RO17.01.2018
RS17.01.2018
SE17.01.2018
SI17.01.2018
SK17.01.2018
SM17.01.2018
BG17.04.2018
NO17.04.2018
GR18.04.2018
LU07.05.2018
IS17.05.2018
Former [2019/13]AL17.01.2018
AT17.01.2018
CY17.01.2018
CZ17.01.2018
DK17.01.2018
EE17.01.2018
ES17.01.2018
FI17.01.2018
HR17.01.2018
IT17.01.2018
LT17.01.2018
LV17.01.2018
MC17.01.2018
PL17.01.2018
RO17.01.2018
RS17.01.2018
SE17.01.2018
SI17.01.2018
SK17.01.2018
SM17.01.2018
BG17.04.2018
NO17.04.2018
GR18.04.2018
IS17.05.2018
Former [2019/06]AL17.01.2018
AT17.01.2018
CY17.01.2018
CZ17.01.2018
DK17.01.2018
EE17.01.2018
ES17.01.2018
FI17.01.2018
HR17.01.2018
IT17.01.2018
LT17.01.2018
LV17.01.2018
MC17.01.2018
PL17.01.2018
RO17.01.2018
RS17.01.2018
SE17.01.2018
SK17.01.2018
SM17.01.2018
BG17.04.2018
NO17.04.2018
GR18.04.2018
IS17.05.2018
Former [2018/52]AL17.01.2018
AT17.01.2018
CY17.01.2018
CZ17.01.2018
DK17.01.2018
EE17.01.2018
ES17.01.2018
FI17.01.2018
HR17.01.2018
IT17.01.2018
LT17.01.2018
LV17.01.2018
PL17.01.2018
RO17.01.2018
RS17.01.2018
SE17.01.2018
SK17.01.2018
SM17.01.2018
BG17.04.2018
NO17.04.2018
GR18.04.2018
IS17.05.2018
Former [2018/51]AL17.01.2018
AT17.01.2018
CY17.01.2018
CZ17.01.2018
DK17.01.2018
EE17.01.2018
ES17.01.2018
FI17.01.2018
HR17.01.2018
IT17.01.2018
LT17.01.2018
LV17.01.2018
PL17.01.2018
RO17.01.2018
RS17.01.2018
SE17.01.2018
SK17.01.2018
BG17.04.2018
NO17.04.2018
GR18.04.2018
IS17.05.2018
Former [2018/50]AL17.01.2018
AT17.01.2018
CY17.01.2018
CZ17.01.2018
EE17.01.2018
ES17.01.2018
FI17.01.2018
HR17.01.2018
IT17.01.2018
LT17.01.2018
LV17.01.2018
PL17.01.2018
RO17.01.2018
RS17.01.2018
SE17.01.2018
SK17.01.2018
BG17.04.2018
NO17.04.2018
GR18.04.2018
IS17.05.2018
Former [2018/49]AL17.01.2018
AT17.01.2018
CY17.01.2018
EE17.01.2018
ES17.01.2018
FI17.01.2018
HR17.01.2018
IT17.01.2018
LT17.01.2018
LV17.01.2018
PL17.01.2018
RO17.01.2018
RS17.01.2018
SE17.01.2018
BG17.04.2018
NO17.04.2018
GR18.04.2018
IS17.05.2018
Former [2018/47]AL17.01.2018
AT17.01.2018
CY17.01.2018
ES17.01.2018
FI17.01.2018
HR17.01.2018
IT17.01.2018
LT17.01.2018
LV17.01.2018
PL17.01.2018
RS17.01.2018
SE17.01.2018
BG17.04.2018
NO17.04.2018
GR18.04.2018
IS17.05.2018
Former [2018/46]AL17.01.2018
AT17.01.2018
CY17.01.2018
ES17.01.2018
FI17.01.2018
HR17.01.2018
LT17.01.2018
LV17.01.2018
PL17.01.2018
RS17.01.2018
SE17.01.2018
BG17.04.2018
NO17.04.2018
GR18.04.2018
IS17.05.2018
Former [2018/40]AT17.01.2018
CY17.01.2018
ES17.01.2018
FI17.01.2018
HR17.01.2018
LT17.01.2018
LV17.01.2018
PL17.01.2018
RS17.01.2018
SE17.01.2018
BG17.04.2018
NO17.04.2018
GR18.04.2018
IS17.05.2018
Former [2018/39]AT17.01.2018
CY17.01.2018
ES17.01.2018
FI17.01.2018
HR17.01.2018
LT17.01.2018
LV17.01.2018
PL17.01.2018
RS17.01.2018
SE17.01.2018
NO17.04.2018
GR18.04.2018
IS17.05.2018
Former [2018/37]CY17.01.2018
ES17.01.2018
FI17.01.2018
HR17.01.2018
LT17.01.2018
PL17.01.2018
NO17.04.2018
GR18.04.2018
Former [2018/36]CY17.01.2018
ES17.01.2018
FI17.01.2018
HR17.01.2018
LT17.01.2018
PL17.01.2018
NO17.04.2018
Former [2018/35]CY17.01.2018
FI17.01.2018
HR17.01.2018
LT17.01.2018
NO17.04.2018
Cited inInternational search[ID]WO0136615  (KOCHANEK STEFAN [DE], et al) [ID] 1-7,9-12,14-16 * the whole document *;
 [ID]  - SCHIEDNER G ET AL, "EFFICIENT TRANSFORMATION OF PRIMARY HUMAN AMNIOCYTES BY E1 FUNCTIONS OF AD5: GENERATION OF NEW CELL LINES FOR ADENOVIRAL VECTOR PRODUCTION", HUMAN GENE THERAPY, MARY ANN LIEBERT, NEW YORK ,NY, US, (20001010), vol. 11, no. 15, doi:10.1089/104303400750001417, ISSN 1043-0342, pages 2105 - 2116, XP000974022 [ID] 1-7,9-12,14-16 * the whole document *

DOI:   http://dx.doi.org/10.1089/104303400750001417
 [X]  - FALLAUX F J ET AL, "NEW HELPER CELLS AND MATCHED EARLY REGION 1-DELETED ADENOVIRUS VECTORS PREVENT GENERATION OF REPLICATION-COMPETENT ADENOVIRUSES", HUMAN GENE THERAPY, (19980901), vol. 9, ISSN 1043-0342, pages 1909 - 1917, XP002943497 [X] 1-7,9,10,14-16 * abstract * * figure 1 *
 [I]  - SCHIEDNER GUDRUN ET AL, "Efficient and reproducible generation of high-expressing, stable human cell lines without need for antibiotic selection", BMC BIOTECHNOLOGY, (20080212), vol. 8, no. 1, ISSN 1472-6750, page 13, XP021035682 [I] 1-7,9-12,14-16 * page 9, column r, paragraph 1 - paragraph 2 * * abstract *
 [A]  - ZHENG ZHI-MING, "Regulation of alternative RNA splicing by exon definition and exon sequences in viral and mammalian gene expression.", JOURNAL OF BIOMEDICAL SCIENCE, (200405), vol. 11, no. 3, pages 278 - 294, XP009164194 [A] 1-16 * abstract * * page 286, column r, paragraph l - page 287, column l, paragraph 1 *

DOI:   http://dx.doi.org/10.1007/BF02254432
 [AD]  - FAIRBROTHER WG ET AL., "Predictive identification of exonic splicing enhancers in human genes", SCIENCE, (2002), vol. 297, pages 1007 - 1013, XP008110822 [AD] 1-16 * the whole document *

DOI:   http://dx.doi.org/10.1126/science.1073774
by applicant   - FIELDS, Virology, LIPPINCOTT-RAVEN PUBLISHING, (1996), pages 2111 - 2148
    - IMPERIALE ET AL., CURR TOP MICROBIOL IMMUNOL, (2004), vol. 273, pages 335 - 57
    - BYRD ET AL., NATURE, (1982), vol. 298, pages 69 - 71
    - HOEHN ET AL., PEDIAT. RES., (1974), vol. 8, pages 746 - 754
    - "DNA cloning: A practical approach", GLOVER, D. M., Expression Systems, IRL PRESS, (1995), vol. II
    - FALLAUX ET AL., HUM GENE THER, (1998), vol. 9, pages 1909 - 17
    - ADRA CN; BOER PH; MCBURNEY MW, "Cloning and expression of the mouse pgk-1 gene and the nucleotide sequence of its promoter", GENE, (1987), vol. 60, doi:doi:10.1016/0378-1119(87)90214-9, pages 65 - 74, XP023544734

DOI:   http://dx.doi.org/10.1016/0378-1119(87)90214-9
    - BANGARI DS; MITTAL SK, "Development of nonhuman adenoviruses as vaccine vectors", VACCINE, (2006), vol. 24, no. 7, doi:doi:10.1016/j.vaccine.2005.08.101, pages 849 - 62, XP028011282

DOI:   http://dx.doi.org/10.1016/j.vaccine.2005.08.101
    - BARON U; GOSSEN M; BUJARD H, "Tetracycline-controlled transcription in eukaryotes: novel transactivators with graded transactivation potential", NUCLEIC ACIDS RES., (19970715), vol. 25, no. 14, doi:doi:10.1093/nar/25.14.2723, pages 2723 - 9, XP002080375

DOI:   http://dx.doi.org/10.1093/nar/25.14.2723
    - BEN-PORATH I; WEINBERG RA, "The signals and pathways activating cellular senescence", INT J BIOCHEM CELL BIOL., (200505), vol. 37, no. 5, doi:doi:10.1016/j.biocel.2004.10.013, pages 961 - 76, XP005282513

DOI:   http://dx.doi.org/10.1016/j.biocel.2004.10.013
    - BERK AJ, "Recent lessons in gene expression, cell cycle control, and cell biology from adenovirus", ONCOGENE, (20051121), vol. 24, no. 52, pages 7673 - 85
    - BLACKFORD AN; GRAND RJ, "Adenovirus E1B 55-kilodalton protein: multiple roles in viral infection and cell transformation", J VIROL., (200905), vol. 83, no. 9, pages 4000 - 12
    - BOSHART M; WEBER F; JAHN G; DORSCH-HASLER K; FLECKENSTEIN B; SCHAFFNER WA, "very strong enhancer is located upstream of an immediate early gene of human cytomegalovirus", CELL, (1985), vol. 41, doi:doi:10.1016/S0092-8674(85)80025-8, pages 521 - 530, XP023913263

DOI:   http://dx.doi.org/10.1016/S0092-8674(85)80025-8
    - BURCIN MM; O'MALLEY BW; TSAI SY, "A regulatory system for target gene expression", FRONT. BIOSCI, (1998), vol. 3, pages CL - C7
    - BURSET M; SELEDTSOV IA; SOLOVYEV VV; SPLICEDB, "database of canonical and non-canonical mammalian splice sites", NUCLEIC ACIDS RES., (2001), vol. 29, pages 255 - 9
    - BYRD P; BROWN KW; GALLIMORE PH, "Malignant transformation of human embryo retinoblasts by cloned adenovirus 12 DNA", NATURE, (1982), vol. 298, no. 5869, pages 69 - 71
    - DAVIES J; JIMENEZ A, "A new selective agent for eukaryotic cloning vectors", AM J TROP MED HYG, (1980), vol. 29, no. 5, pages 1089 - 92, XP001284280
    - DORSCH-HASLER K; KEIL GM; WEBER F; JASIN M; SCHAFFNER W; KOSZINOWSKI UH, "A long and complex enhancer activates transcription of the gene coding for the highly abundant immediate early mRNA in murine cytomegalovirus", PROC NATL ACAD SCI U S A., (1985), vol. 82, doi:doi:10.1073/pnas.82.24.8325, pages 8325 - 8329, XP001160761

DOI:   http://dx.doi.org/10.1073/pnas.82.24.8325
    - ENDTER C; KZHYSHKOWSKA J; STAUBER R; DOBNER T, "SUMO-1 modification required for transformation by adenovirus type 5 early region 1 B 55-kDa oncoprotein", PROC NATL ACAD SCI U S A., (20010925), vol. 98, no. 20, pages 11312 - 7
    - FAIRBROTHER WG.; YEH RF.; SHARP PA.; BURGE CB., "Predictive identification of exonic splicing enhancers in human genes", SCIENCE, (2002), vol. 297, doi:doi:10.1126/science.1073774, pages 1007 - 1013, XP008110822

DOI:   http://dx.doi.org/10.1126/science.1073774
    - FAIRBROTHER WG; YEO GW; YEH R; GOLDSTEIN P; MAWSON M; SHARP, PA; BURGE CB, "RESCUE-ESE identifies candidate exonic splicing enhancers in vertebrate exons", NUCLEIC ACIDS RES., (2004), vol. 32, pages W187 - 190
    - FALLAUX FJ; BOUT A; VAN DER VELDE I; VAN DEN WOLLENBERG DJ; HEHIR KM; KEEGAN J; AUGER C; CRAMER SJ; VAN ORMONDT H; VAN DER EB AJ, "New helper cells and matched early region 1-deleted adenovirus vectors prevent generation of replication-competent adenoviruses", HUM GENE THER., (19980901), vol. 9, no. 13, pages 1909 - 17
    - FALLAUX FJ; KRANENBURG O; CRAMER SJ; HOUWELING A; VAN ORMONDT H; HOEBEN RC; VAN DER EB AJ, "Characterization of 911: a new helper cell line for the titration and propagation of early region 1-deleted adenoviral vectors", HUM GENE THER., (19960120), vol. 7, no. 2, pages 215 - 22
    - GALLIMORE PH; GRAND RJ; BYRD PJ, "Transformation of human embryo retinoblasts with simian virus 40, adenovirus and ras oncogenes", ANTICANCER RES, (1986), vol. 6, no. 3, pages 499 - 508, XP008020458
    - GAO W; ROBBINS PD; GAMBOTTO A, "Human adenovirus type 35: nucleotide sequence and vector development", GENE THER., (200311), vol. 10, no. 23, doi:doi:10.1038/sj.gt.3302097, pages 1941 - 9, XP008155597

DOI:   http://dx.doi.org/10.1038/sj.gt.3302097
    - GRAHAM FL; SMILEY J; RUSSELL WC; NAIRN R, "Characteristics of a human cell line transformed by DNA from human adenovirus type 5", J GEN VIROL, (1977), vol. 36, no. 1, doi:doi:10.1099/0022-1317-36-1-59, pages 59 - 74, XP008153803

DOI:   http://dx.doi.org/10.1099/0022-1317-36-1-59
    - HARLEY CB; FUTCHER AB; GREIDER CW, "Telomeres shorten during ageing of human fibroblasts", NATURE, (19900531), vol. 345, no. 6274, pages 458 - 60
    - HEHIR KM; ARMENTANO D; CARDOZA LM; CHOQUETTE TL; BERTHELETTE PB; WHITE GA; COUTURE LA; EVERTON MB; KEEGAN J; MARTIN JM, "Molecular characterization of replication-competent variants of adenovirus vectors and genome modifications to prevent their occurrence", J VIROL., (199612), vol. 70, no. 12, pages 8459 - 67, XP002911790
    - HOEHN H; BRYANT EM; KARP LE; MARTIN GM, "Cultivated cells from diagnostic amniocentesis in second trimester pregnancies", I. CLONAL MORPHOLOGY AND GROWTH POTENTIAL. PEDIATR RES., (197408), vol. 8, no. 8, pages 746 - 54
    - HU MC; DAVIDSON N, "The inducible lac operator-repressor system is functional in mammalian cells", CELL, (1987), vol. 48, doi:doi:10.1016/0092-8674(87)90234-0, pages 555 - 566, XP001056394

DOI:   http://dx.doi.org/10.1016/0092-8674(87)90234-0
    - HYNES NE; GRONER B, "Mammary tumor formation and hormonal control of mouse mammary tumor virus expression", CURR TOP MICROBIOL IMMUNOL., (1982), vol. 10, no. 1, pages 51 - 74
    - IMPERIALE MJ; KOCHANEK S, "Adenovirus vectors: biology, design, and production", CURR TOP MICROBIOL IMMUNOL., (2004), vol. 273, pages 335 - 57, XP009070614
    - KIM N; ALEKSEYENKO AV; ROY M; LEE C, "The ASAP II database: analysis and comparative genomics of alternative splicing in 15 animal species", NUCLEIC ACIDS RES., (2007), vol. 35, pages D93 - 98
    - LOEW R; HEINZ N; HAMPFM; BUJARD H; GOSSEN M, "Improved Tet-responsive promoters with minimized background expression", BMC BIOTECHNOL., (20101124), vol. 10, doi:doi:10.1186/1472-6750-10-81, page 81, XP021087812

DOI:   http://dx.doi.org/10.1186/1472-6750-10-81
    - LOUIS N; EVELEGH C; GRAHAM FL, "Cloning and sequencing of the cellular-viral junctions from the human adenovirus type 5 transformed 293 cell line", VIROLOGY, (1997), vol. 233, no. 2, doi:doi:10.1006/viro.1997.8597, pages 423 - 9, XP004452203

DOI:   http://dx.doi.org/10.1006/viro.1997.8597
    - LOCHMULLER H; JANI A; HUARD J; PRESCOTT S; SIMONEAU M; MASSIE B; KARPATI G; ACSADI G, "Emergence of early region 1-containing replication-competent adenovirus in stocks of replication-defective adenovirus recombinants (delta E1 + delta E3) during multiple passages in 293 cells", HUM GENE THER., (199412), vol. 5, no. 12, pages 1485 - 91
    - MCCONNELL MJ; IMPERIALE MJ, "Biology of adenovirus and its use as a vector for gene therapy", HUM GENE THER, (2004), vol. 15, no. 11, pages 1022 - 33
    - MURAKAMI P; HAVENGA M; FAWAZ F; VOGELS R; MARZIO G; PUNGOR E; FILES J; DO L; GOUDSMIT J; MCCAMAN M, "Common structure of rare replication-deficient E1-positive particles in adenoviral vector batches", J VIROL., (200406), vol. 78, no. 12, pages 6200 - 8
    - MURAKAMI P; PUNGOR E; FILES J; DO L; VAN RIJNSOEVER R; VOGELS R; BOUT A; MCCAMAN M, "A single short stretch of homology between adenoviral vector and packaging cell line can give rise to cytopathic effect-inducing, helper-dependent E1-positive particles", HUM GENE THER., (20020520), vol. 13, no. 8, doi:doi:10.1089/10430340252939023, pages 909 - 20, XP002278921

DOI:   http://dx.doi.org/10.1089/10430340252939023
    - NO D; YAO TP; EVANS RM, "Ecdysone-inducible gene expression in mammalian cells and transgenic mice", PROC NATL ACAD SCI U S A, (1996), vol. 93, doi:doi:10.1073/pnas.93.8.3346, pages 3346 - 3351, XP002036328

DOI:   http://dx.doi.org/10.1073/pnas.93.8.3346
    - PARKS RJ; CHEN L; ANTON M; SANKAR U; RUDNICKI MA; GRAHAM FL, "A helper-dependent adenovirus vector system: removal of helper virus by Cre-mediated excision of the viral packaging signal", PROC NATL ACAD SCI U S A., (19961126), vol. 93, no. 24, pages 13565 - 70
    - PESOLE G; MIGNONE F; GISSI C; GRILLO G; LICCIULLI F; LIUNI S, "Structural and functional features of eukaryotic mRNA untranslated regions", GENE, (2001), vol. 276, pages 73 - 8
    - PROUDFOOT NJ, "Ending the message: poly(A)signals then and now", GENES DEV., (2011), vol. 25, pages 1770 - 82
    - SAMOW P; SULLIVAN CA; LEVINE AJ, "A monoclonal antibody detecting the adenovirus type 5-Elb-58Kd tumor antigen: characterization of the Elb-58Kd tumor antigen in adenovirus- infected and -transformed cells", VIROLOGY, (19820730), vol. 120, no. 2, pages 510 - 7
    - SCHIEDNER G; HERTEL S; BIALEK C; KEWES H; WASCHUTZA G; VOLPERS C, "Efficient and reproducible generation of high-expressing, stable human cell lines without need for antibiotic selection", BMC BIOTECHNOL., (20080212), vol. 8, page 13, XP021035682
    - SCHIEDNER G; HERTEL S; KOCHANEK S, "Efficient transformation of primary human amniocytes by E1 functions of Ad5: generation of new cell lines for adenoviral vector production", HUM GENE THER., (20001010), vol. 11, no. 15, pages 2105 - 16
    - SIEBER T; DOBNER T, "Adenovirus type 5 early region 1B 156R protein promotes cell transformation independently of repression of p53-stimulated transcription", J VIROL., (200701), vol. 81, no. 1, pages 95 - 105
    - SILVA AC; PEIXOTO C; LUCAS T; KIIPPERS C; CRUZ PE; ALVES PM; KOCHANEK S, "Adenovirus vector production and purification", CURR GENE THER., (201012), vol. 10, no. 6, pages 437 - 55
    - SINGER-SAM J; KEITH DH; TANI K; SIMMER RL.; SHIVELY L; LINDSAY S; YOSHIDA A; RIGGS AD, "Sequence of the promoter region of the gene for human X-linked 3-phosphoglycerate kinase", GENE, (1984), vol. 32, doi:doi:10.1016/0378-1119(84)90016-7, pages 409 - 417, XP023538507

DOI:   http://dx.doi.org/10.1016/0378-1119(84)90016-7
    - SCHREINER S; WIMMER P; GROITL P; CHEN SY; BLANCHETTE P; BRANTON PE; DOBNER T, "Adenovirus type 5 early region 1B 55K oncoprotein-dependent degradation of cellular factor Daxx is required for efficient transformation of primary rodent cells", J VIROL., (201109), vol. 85, no. 17, pages 8752 - 65
    - TOUSSAINT O; MEDRANO EE; VON ZGLINICKI T, "Cellular and molecular mechanisms of stress-induced premature senescence (SIPS) of human diploid fibroblasts and melanocytes", EXP GERONTOL., (200010), vol. 35, no. 8, pages 927 - 45
    - UMAFIA P; GERDES CA; STONE D; DAVIS JR; WARD D; CASTRO MG; LOWENSTEIN PR, "Efficient FLPe recombinase enables scalable production of helper-dependent adenoviral vectors with negligible helper-virus contamination", NAT BIOTECHNOL., (200106), vol. 19, no. 6, doi:doi:10.1038/89349, pages 5 82 - 5, XP002988918

DOI:   http://dx.doi.org/10.1038/89349
    - VOGELS R; ZUIJDGEEST D; VAN RIJNSOEVER R; HARTKOORN E; DAMEN I; DE BETHUNE MP; KOSTENSE S; PENDERS G; HELMUS N; KOUDSTAAL W, "Replication-deficient human adenovirus type 35 vectors for gene transfer and vaccination: efficient human cell infection and bypass of preexisting adenovirus immunity", J VIROL., (200308), vol. 77, no. 15, pages 8263 - 71
    - WHITTAKER JL; BYRD PJ; GRAND RJ; GALLIMORE PH, "Isolation and characterization of four adenovirus type 12-transformed human embryo kidney cell lines", MOL CELL BIOL., (198401), vol. 4, no. 1, pages 110 - 6
    - WURM FM; GWINN KA; KINGSTON RE, "Inducible overproduction of the mouse c-myc protein in mammalian cells", PROC NATL ACAD SCI U S A., (1986), vol. 83, pages 5414 - 5418
 EP20000979539
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.